ACLY and lung cancer: Conversely, the down-regulation of ACLY by miR-22 was shown to attenuate cancer cell proliferation and invasion, as well as promote cell apoptosis in different types of tumor cells including osteosarcoma, prostate, cervical, and lung cancers [53].